As European medtech companies look to expand their presence in the U.S. market, understanding the intricacies of U.S. patent law becomes increasingly important.
| less than a minute read
European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success

/Passle/682d9272975255c09721f33f/MediaLibrary/Images/2025-05-22-15-04-09-247-682f3ce9836e432762e235d5.jpg)
/Passle/682d9272975255c09721f33f/MediaLibrary/Images/2025-05-22-15-04-09-202-682f3ce9e23afcc7d8af12dc.jpg)
/Passle/682d9272975255c09721f33f/SearchServiceImages/2025-08-21-16-19-12-312-68a74700b00cc03ddb6821e2.jpg)
/Passle/682d9272975255c09721f33f/SearchServiceImages/2025-08-20-21-20-57-853-68a63c397b1df7dfa3676fa5.jpg)